Role of T Helper 17 and Regulatory T Cells in Delayed Graft Function
Can T Helper 17 and Regulatory T Cells Explain the Pathophysiology of Delayed Graft Function in Renal Transplant Recipients?
1 other identifier
observational
50
1 country
1
Brief Summary
Delayed graft function (DGF) increases risk of acute rejection after kidney transplantation (KTx). Interleukin-6, which is produced in DGF, is critical in directing naive T helper cells differentiation towards T helper 17 (Th17) and away from regulatory T (Treg) cells. The investigators hypothesize there is an increase in Th17 and a decrease in Treg expression in KTx recipients with DGF compared to those without, leading to immunologic consequences. The investigators will test their hypothesis by measuring in both groups expression of Th17, Treg, and related cytokines in blood, urine, kidney biopsy, and kidney preservation fluid, and correlating these results with immunologic events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 30, 2010
CompletedFirst Posted
Study publicly available on registry
November 2, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedSeptember 14, 2016
September 1, 2016
8.4 years
October 30, 2010
September 12, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Graft function
Kidney graft function as measured by GFR
1 year
Study Arms (2)
Delayed graft function
These are patients in whom dialysis is required following transplantation.
Immediate function
These are patients in whom no dialysis is required and creatinine declines by \>20% in the first 24 hours following transplantation.
Eligibility Criteria
All kidney transplant recipients at our institution will be recruited prior to their operative procedure.
You may qualify if:
- Kidney transplant recipients
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McGill University Health Center
Montreal, Quebec, H3A 1A1, Canada
Related Publications (1)
Nguyen MT, Fryml E, Sahakian SK, Liu S, Cantarovich M, Lipman M, Tchervenkov JI, Paraskevas S. Pretransplant Recipient Circulating CD4+CD127lo/- Tumor Necrosis Factor Receptor 2+ Regulatory T Cells: A Surrogate of Regulatory T Cell-Suppressive Function and Predictor of Delayed and Slow Graft Function After Kidney Transplantation. Transplantation. 2016 Feb;100(2):314-24. doi: 10.1097/TP.0000000000000942.
PMID: 26425877DERIVED
Biospecimen
Urine Kidney biopsy Kidney preservation fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Paraskevas, MD PhD
McGill University Health Centre/Research Institute of the McGill University Health Centre
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Surgery
Study Record Dates
First Submitted
October 30, 2010
First Posted
November 2, 2010
Study Start
July 1, 2010
Primary Completion
December 1, 2018
Study Completion
December 1, 2019
Last Updated
September 14, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make the experimental data available to participants. Their clinical data, however, is available to them through their treating physician.